SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Christos Sachpekidis, Elias K. Mai, Hartmut Goldschmidt, Jens Hillengass, Dirk Hose, Leyun Pan, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss, 18F-FDG Dynamic PET/CT in Patients with Multiple Myeloma, Clinical Nuclear Medicine, 2015, 40, 6, e300

    CrossRef

  2. 2
    Ewa Bednaruk-Młyński, Joanna Pieńkowska, Adam Skórzak, Bogdan Małkowski, Waldemar Kulikowski, Edyta Subocz, Justyna Dzietczenia, Marta Zalewska, Krzysztof Leśniewski-Kmak, Renata Zaucha, Tomasz Wróbel, Jan M. Zaucha, Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma, Leukemia & Lymphoma, 2015, 56, 2, 377

    CrossRef

  3. 3
    Christian Uprimny, PET in lymphoma: who, when, how often, pitfalls?, memo - Magazine of European Medical Oncology, 2015, 8, 1, 43

    CrossRef

  4. 4
    Michal Weiler-Sagie, Olga Kagna, Eldad J. Dann, Ayelet Ben-Barak, Ora Israel, Characterizing bone marrow involvement in Hodgkin’s lymphoma by FDG-PET/CT, European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 6, 1133

    CrossRef

  5. 5
    M. Revest, S. Patrat-Delon, A. Devillers, P. Tattevin, C. Michelet, Contribution of 18fluoro-deoxyglucose PET/CT for the diagnosis of infectious diseases, Médecine et Maladies Infectieuses, 2014, 44, 6, 251

    CrossRef

  6. 6
    Lale Kostakoglu, Bruce D. Cheson, Current role of FDG PET/CT in lymphoma, European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 5, 1004

    CrossRef

  7. 7
    Douglas Sidell, Robert S. Venick, Nina L. Shapiro, Epstein-barr DNA serology and positron-emission tomography imaging of the head and neck in pediatric transplant recipients, The Laryngoscope, 2014, 124, 5
  8. 8
    Karen Juul Mylam, Anne Lerberg Nielsen, Lars Møller Pedersen, Martin Hutchings, Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma, PET Clinics, 2014, 9, 4, 443

    CrossRef

  9. 9
    Jihen Ben Amar, Mouna Berrais, Leila El Gharbi, Besma Dhahri, Hichem Aouina, Hend Bouacha, Hématopoïèse extramédullaire révélant une bêta-thalassémie, La Presse Médicale, 2014, 43, 11, 1290

    CrossRef

  10. 10
    Quoc Truong, Nilay Shah, Mark Knestrick, Brendan Curley, Yanqing Hu, Michael Craig, Mehdi Hamadani, Limited Utility of Surveillance Imaging for Detecting Disease Relapse in Patients With Non-Hodgkin Lymphoma in First Complete Remission, Clinical Lymphoma Myeloma and Leukemia, 2014, 14, 1, 50

    CrossRef

  11. 11
    Andrew Bryce Crush, Benjamin Matthew Howe, Robert J. Spinner, Kimberly K. Amrami, Christopher Harker Hunt, Geoffrey B. Johnson, Robert C. Murphy, Robert F. Morreale, Patrick J. Peller, Malignant Involvement of the Peripheral Nervous System in Patients with Cancer: Multimodality Imaging and Pathologic Correlation, RadioGraphics, 2014, 34, 7, 1987

    CrossRef

  12. 12
    Akio Akagi, Kenjiro Ono, Tsuyoshi Hamaguchi, Miharu Samuraki, Mitsutoshi Nakada, Yukiko Shima, Tetuya Oohata, Masahito Yamada, Neurolymphomatosis exhibiting repeated exacerbation and remission in both the peripheral and central nervous systems, Journal of the Neurological Sciences, 2014, 345, 1-2, 267

    CrossRef

  13. 13
    P Sidhu, P Lin, H Son, D Rosenfeld, M Lin, Testicular fluorine-18 fludeoxyglucose uptake on positron emission tomography CT in patients with lymphoma: clinical significance and management impact, The British Journal of Radiology, 2014, 87, 1044, 20140472

    CrossRef

  14. 14
    Zhou Lu, Michael Lin, Paul Downe, Shanley Chong, Silvia Ling, The prognostic value of mid- and post-treatment [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma, Annals of Nuclear Medicine, 2014, 28, 8, 805

    CrossRef

  15. 15
    A. M. Evens, L. Kostakoglu, The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease, Hematology, 2014, 2014, 1, 135

    CrossRef

  16. 16
    A. M. Evens, L. Kostakoglu, The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease, Blood, 2014, 124, 23, 3356

    CrossRef

  17. 17
    Sellam Karunanithi, Punit Sharma, Shambo Guha Roy, Beth Vettiyil, Atul Sharma, Sanjay Thulkar, Chandrasekhar Bal, Rakesh Kumar, Use of 18F-FDG PET/CT Imaging for Evaluation of Patients With Primary Splenic Lymphoma, Clinical Nuclear Medicine, 2014, 39, 9, 772

    CrossRef

  18. 18
    Tomoyuki Yamaguchi, Masaya Shinbo, A case of primary malignant lymphoma of the lung with pleural dissemination, The Journal of the Japanese Association for Chest Surgery, 2013, 27, 2, 170

    CrossRef

  19. 19
    Michihiro Nakayama, Atsutaka Okizaki, Shunta Ishitoya, Miki Sakaguchi, Junichi Sato, Tamio Aburano, Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions, Annals of Nuclear Medicine, 2013, 27, 2, 163

    CrossRef

  20. 20
    Irit Avivi, Ariel Zilberlicht, Eldad J. Dann, Ronit Leiba, Tal Faibish, Jacob M. Rowe, Rachel Bar-Shalom, Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era, American Journal of Hematology, 2013, 88, 5
  21. 21
    Juliano Julio Cerci, Carlos Cunha Pereira Neto, Cassiano Krauzer, Danielle Giacometti Sakamoto, João Vicente Vitola, The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients, European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40, 1, 98

    CrossRef

  22. 22
    Massimo Gentile, Giovanna Cutrona, Sonia Fabris, Emanuela Anna Pesce, Luca Baldini, Francesco Raimondo, Caterina Musolino, Paolo Tonno, Nicola Renzo, Stefano Molica, Maura Brugiatelli, Fiorella Ilariucci, Simona Zupo, Serena Matis, Francesco Maura, Ernesto Vigna, Francesco Angrilli, Anna Grazia Recchia, Giovanni Quarta, Emilio Iannitto, Alberto Fragasso, Pellegrino Musto, Mauro Spriano, Iolanda Vincelli, Daniele Vallisa, Agostino Cortelezzi, Francesca Romana Mauro, Robin Foà, Massimo Federico, Antonino Neri, Manlio Ferrarini, Fortunato Morabito, Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study, American Journal of Hematology, 2013, 88, 7
  23. 23
    Jing Zhang, Bobin Chen, Xiaoping Xu, Zhiguang Lin, Bo Huang, Jing Song, Guowei Lin, Clinical Features of 66 Lymphoma Patients Presenting with a Fever of Unknown Origin, Internal Medicine, 2012, 51, 18, 2529

    CrossRef

  24. 24
    Takayoshi Shinya, Soichiro Fujii, Shoji Asakura, Toshitaka Taniguchi, Kotaro Yoshio, Aierken Alafate, Shuhei Sato, Tadashi Yoshino, Susumu Kanazawa, Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma, Annals of Nuclear Medicine, 2012, 26, 8, 616

    CrossRef

  25. 25
    Juliano Julio Cerci, Lucia Zanoni, José C. Meneghetti, Stefano Fanti, FDG-PET in Lymphoma: Nuclear Medicine Perspective, PET Clinics, 2012, 7, 1, 21

    CrossRef

  26. 26
    Yoon Jung Lee, Jun Haeng Lee, Gastrointestinal Lymphoma, The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2012, 12, 3, 158

    CrossRef

  27. 27
    Mario Otto, Barry L. Shulkin, Mondira Kundu, John T. Sandlund, Scott E. Snyder, Monika L. Metzger, Histiocyte-rich Xanthomatous Pseudotumor Mimicking Relapse on Positron Emission Tomography Imaging in an Adolescent With Primary Mediastinal Diffuse Large B-cell Lymphoma, Journal of Pediatric Hematology/Oncology, 2012, 34, 3, 232

    CrossRef

  28. 28
    Silvia Taralli, Maria Lucia Calcagni, Vittoria Rufini, Luca Laurenti, Simona Sica, Patrizia Chiusolo, Giuseppe Leone, Alessandro Giordano, Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients, Annals of Nuclear Medicine, 2012, 26, 9, 764

    CrossRef

  29. 29
    A. Afshar-Oromieh, C. Kratochwil, U. Haberkorn, F.L. Giesel, Stellenwert der PET/CT in der Lymphomdiagnostik, Der Radiologe, 2012, 52, 4, 338

    CrossRef

  30. 30
    S. F. Barrington, J. E. MacKewn, P. Schleyer, P. K. Marsden, N. G. Mikhaeel, W. Qian, P. Mouncey, P. Patrick, B. Popova, P. Johnson, J. Radford, M. J. O'Doherty, Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma, Annals of Oncology, 2011, 22, 3, 739

    CrossRef

  31. 31
    Xavier Setoain, Armando López-Guillermo, Estadificación de los linfomas no hodgkinianos con PET-TC, Medicina Clínica, 2011, 137, 9, 402

    CrossRef

  32. 32
    Yen-Kung Chen, Chia-Lu Yeh, Chih-Cheng Tsui, Ji-An Liang, Jin-Hua Chen, Chia-Hung Kao, F-18 FDG PET for Evaluation of Bone Marrow Involvement in Non-Hodgkin Lymphoma, Clinical Nuclear Medicine, 2011, 36, 7, 553

    CrossRef

  33. 33
    A. Broucqsault, A. Ouzzane, D. Launay, X. Leroy, C. Rose, A. Villers, J.-C. Fantoni, Hématopoïèse extramédullaire rénale, Progrès en Urologie, 2011, 21, 8, 575

    CrossRef

  34. 34
    Shingo Baba, Koichiro Abe, Takuro Isoda, Yasuhiro Maruoka, Masayuki Sasaki, Hiroshi Honda, Impact of FDG-PET/CT in the management of lymphoma, Annals of Nuclear Medicine, 2011, 25, 10, 701

    CrossRef

  35. 35
    Malou A Vermoolen, Marie José Kersten, Rob Fijnheer, Maarten S van Leeuwen, Thomas C Kwee, Rutger AJ Nievelstein, Magnetic resonance imaging of malignant lymphoma, Expert Review of Hematology, 2011, 4, 2, 161

    CrossRef

  36. 36
    J.M. Warwick, M.M. Sathekge, PET/CT scanning with a high HIV/AIDS prevalence, Transfusion and Apheresis Science, 2011, 44, 2, 167

    CrossRef

  37. 37
    X. Setoain, A. López-Guillermo, S. Rodríguez, I. Navales, TEP/TDM dans le diagnostic et la stadification des lymphomes, Médecine Nucléaire, 2011, 35, 1, 4

    CrossRef

  38. 38
    Neta Goldschmidt, Omer Or, Martine Klein, Bella Savitsky, Ora Paltiel, The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma, Annals of Hematology, 2011, 90, 2, 165

    CrossRef

  39. 39
    Hideyuki Nishiofuku, Shigeru Matsushima, Yoshitaka Inaba, Hidekazu Yamaura, Yozo Sato, Yasuo Morishima, Kimihiko Kichikawa, Cellular Density Evaluation for Malignant Lymphoma Using Equivalent Cross-Relaxation Rate Imaging - Initial Experience, Korean Journal of Radiology, 2010, 11, 3, 327

    CrossRef

  40. 40
    Henk Boot, Diagnosis and staging in gastrointestinal lymphoma, Best Practice & Research Clinical Gastroenterology, 2010, 24, 1, 3

    CrossRef

  41. 41
    Fabio M. Paes, Dimitrios G. Kalkanis, Panagiotis A. Sideras, Aldo N. Serafini, FDG PET/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease1, RadioGraphics, 2010, 30, 1, 269

    CrossRef

  42. 42
    Masahiro Okada, Norihide Sato, Kazunari Ishii, Kaname Matsumura, Makoto Hosono, Takamichi Murakami, FDG PET/CT versus CT, MR Imaging, and67Ga Scintigraphy in the Posttherapy Evaluation of Malignant Lymphoma1, RadioGraphics, 2010, 30, 4, 939

    CrossRef

  43. 43
    Dimitrios Kalkanis, Maria Kalkani, Hilton Gomes, Fabio Paes, Panagiotis Sideras, George N. Sfakianakis, FDG-PET/CT in Primary Large B-Cell Lymphoma of the Hard Palate, Clinical Nuclear Medicine, 2010, 35, 1, 24

    CrossRef

  44. 44
    Kunihiko Izuishi, Yuka Yamamoto, Takanori Sano, Ryusuke Takebayashi, Tsutomu Masaki, Yasuyuki Suzuki, Impact of 18-Fluorodeoxyglucose Positron Emission Tomography on the Management of Pancreatic Cancer, Journal of Gastrointestinal Surgery, 2010, 14, 7, 1151

    CrossRef

  45. 45
    S. Adib, X. Leleu, D. Robu, D. Huglo, M. Steinling, La TEP au 18F-FDG dans le diagnostic et le suivi évolutif des plasmocytomes solitaires, Médecine Nucléaire, 2010, 34, 2, 88

    CrossRef

  46. 46
    Ukihide Tateishi, Takashi Terauchi, Tomio Inoue, Kensei Tobinai, Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: PET/CT, Abdominal Imaging, 2010, 35, 2, 232

    CrossRef

  47. 47
    Shonit Punwani, Stuart A. Taylor, Alan Bainbridge, Vineet Prakash, Steven Bandula, Enrico De Vita, Oystein E. Olsen, Sharon F. Hain, Nicola Stevens, Stephen Daw, Ananth Shankar, Jamshed B. Bomanji, Paul D. Humphries, Pediatric and Adolescent Lymphoma:Comparison of Whole-Body STIR Half-Fourier RARE MR Imaging with an Enhanced PET/CT Reference for Initial Staging1, Radiology, 2010, 255, 1, 182

    CrossRef

  48. 48
    Thomas Schrepfer, Stephan K. Haerle, Klaus Strobel, Niklaus Schaefer, Roger A. Hälg, Gerhard F. Huber, The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas, The Laryngoscope, 2010, 120, 5
  49. 49
    Stefan Norin, Eva Kimby, Jeanette Lundin, Tumor burden status evaluated by computed tomography scan is of prognostic importance in patients with chronic lymphocytic leukemia, Medical Oncology, 2010, 27, 3, 820

    CrossRef

  50. 50
    Loukia S. Poulou, Loukas Thanos, Panayiotis D. Ziakas, Unifying the predictive value of pretransplant FDG PET in patients with lymphoma: a review and meta-analysis of published trials, European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37, 1, 156

    CrossRef

  51. 51
    C. Ramos-Font, Á.C. Rebollo Aguirre, R. Villegas Portero, A. Romero Tabares, M. Gallego Peinado, J.M. Llamas Elvira, 18F-fluorodeoxyglucose positron emission tomography in the evaluation of therapy response assessment in lymphomas. Systematic literature review and meta-analysis, Revista Española de Medicina Nuclear (English Edition), 2009, 28, 2, 48

    CrossRef

  52. 52
    Christian von Falck, Thomas Rodt, Steffen Joerdens, Stephan Waldeck, Holger Kiesel, Wolfram H. Knapp, Michael Galanski, F-18 2-Fluoro-2-Deoxy-Glucose Positron Emission Tomography/Computed Tomography for the Detection of Radicular and Peripheral Neurolymphomatosis, Clinical Nuclear Medicine, 2009, 34, 8, 493

    CrossRef

  53. 53
    Loukia S. Poulou, George Karianakis, Panayiotis D. Ziakas, FDG PET scan strategies and long-term outcomes after first-line therapy in Hodgkin's Disease, European Journal of Radiology, 2009, 70, 3, 499

    CrossRef

  54. 54
    Hani Mawardi, Corey Cutler, Nathaniel Treister, Medical management update: Non-Hodgkin lymphoma, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2009, 107, 1, e19

    CrossRef

  55. 55
    Dimitri Papathanassiou, Claire Bruna-Muraille, Jean-Claude Liehn, Tan Dat Nguyen, Hervé Curé, Positron Emission Tomography in oncology: Present and future of PET and PET/CT, Critical Reviews in Oncology/Hematology, 2009, 72, 3, 239

    CrossRef

  56. 56
    R. Crocchiolo, F. Fallanca, G. Giovacchini, A. J. M. Ferreri, A. Assanelli, C. Verona, A. Pescarollo, M. Bregni, M. Ponzoni, L. Gianolli, F. Fazio, F. Ciceri, Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin’s lymphoma, Annals of Hematology, 2009, 88, 12, 1229

    CrossRef

  57. 57
    Yasuhiro Yamamoto, Toshiaki Taoka, Hirokazu Nakamine, Superior Clinical Impact of FDG-PET Compared to MRI for the Follow-up of a Patient with Sacral Lymphoma, Journal of Clinical and Experimental Hematopathology, 2009, 49, 2, 109

    CrossRef

  58. 58
    W.H. Knapp, Szintigraphie und Single-Photon-Emissions-Computertomographie (SPECT und PET), Der Onkologe, 2009, 15, 5, 474

    CrossRef

  59. 59
    C. Ramos-Font, Á.C. Rebollo Aguirre, R. Villegas Portero, A. Romero Tabares, M. Gallego Peinado, J.M. Llamas Elvira, Tomografía de positrones con 18F-fluorodesoxiglucosa en la valoración de la respuesta de los linfomas al tratamiento. Revisión sistemática de la literatura y metaanálisis, Revista Española de Medicina Nuclear, 2009, 28, 2, 48

    CrossRef

  60. 60
    Lale Kostakoglu, [18F]Fluorodeoxyglucose Positron Emission Tomography in the Management of Lymphomas, Clinical Lymphoma and Myeloma, 2008, 8, 5, 273

    CrossRef

  61. 61
    Kayako Isohashi, Mitsuaki Tatsumi, Ichiro Higuchi, Atsuo Inoue, Kazuya Nakajo, Jun Ishikawa, Eku Shimosegawa, Yuzuru Kanakura, Hironobu Nakamura, Jun Hatazawa, 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence, Annals of Nuclear Medicine, 2008, 22, 9, 795

    CrossRef

  62. 62
    Shuo Li, Hua-dan Xue, Jian Li, Fei Sun, Bo Jiang, Dong Liu, Hong-yi Sun, Zheng-yu Jin, Application Of Whole Body Diffusion Weighted MR Imaging for Diagnosis and Staging of Malignant Lymphoma, Chinese Medical Sciences Journal, 2008, 23, 3, 138

    CrossRef

  63. 63
    Charoula S. Tsamita, Arber Golemi, Lapci Egesta, Paolo Castellucci, Cristina Nanni, Vittorio Stefoni, Gaia Grassetto, Domenico Rubello, Monica Tani, Pier Luigi Zinzani, Stefano Fanti, Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET, Nuclear Medicine Communications, 2008, 29, 8, 705

    CrossRef

  64. 64
    Naoto Watanabe, Jun Murakami, Keisuke Kameda, Hiroshi Kato, Yuichi Kamisaki, Kyo Noguchi, Hisashi Funada, Hikaru Seto, F-18 FDG-PET Imaging in Adult T-Cell Leukemia Lymphoma, Clinical Nuclear Medicine, 2008, 33, 6, 423

    CrossRef

  65. 65
    Rebecca L. Elstrom, John P. Leonard, FDG-PET scans in patients with lymphoma, Current Hematologic Malignancy Reports, 2008, 3, 4, 197

    CrossRef

  66. 66
    Pek-Lan Khong, Clara B. Y. Pang, Raymond Liang, Yok-Lam Kwong, Wing-Yan Au, Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies, Annals of Hematology, 2008, 87, 8, 613

    CrossRef

  67. 67
    Andrew Wirth, Marcus Foo, John F. Seymour, Michael P. MacManus, Rodney J. Hicks, Impact of [18F] Fluorodeoxyglucose Positron Emission Tomography on Staging and Management of Early-Stage Follicular Non-Hodgkin Lymphoma, International Journal of Radiation Oncology*Biology*Physics, 2008, 71, 1, 213

    CrossRef

  68. You have free access to this content68
    M Lin, J Kilanowska, J Taper, J Chu, Neurolymphomatosis—diagnosis and assessment of treatment response by FDG PET-CT, Hematological Oncology, 2008, 26, 1
  69. 69
    Bruce D. Cheson, New Staging and Response Criteria for Non-Hodgkin Lymphoma and Hodgkin Lymphoma, Radiologic Clinics of North America, 2008, 46, 2, 213

    CrossRef

  70. 70
    Tsuyoshi Morimoto, Ukihide Tateishi, Tetsuo Maeda, Yasuaki Arai, Yasuo Nakajima, E. Edmund Kim, Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: Comparison of integrated PET/CT with or without contrast enhancement, European Journal of Radiology, 2008, 67, 3, 508

    CrossRef

  71. 71
    J. Dupuis, E. Itti, A. Rahmouni, F. Hemery, C. Gisselbrecht, C. Lin, C. Copie-Bergman, K. Belhadj, T. El Gnaoui, I. Gaillard, F. Kuhnowski, M. Meignan, C. Haioun, Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphoma: integrating 18fluorodeoxyglucose positron emission tomography to the International Workshop Criteria, Annals of Oncology, 2008, 20, 3, 503

    CrossRef

  72. 72
    E. Pelosi, P. Pregno, D. Penna, D. Deandreis, A. Chiappella, G. Limerutti, U. Vitolo, M. Mancini, G. Bisi, E. Gallo, Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma, La radiologia medica, 2008, 113, 4, 578

    CrossRef

  73. 73
    Bruce D. Cheson, Staging and Evaluation of the Patient with Lymphoma, Hematology/Oncology Clinics of North America, 2008, 22, 5, 825

    CrossRef

  74. 74
    Javier Altamirano, Jorge Reyes Esparza, Jaime de la Garza Salazar, Pedro Sobrevilla Calvo, Silvia Rivas Vera, Juan Ramón Chalapud Revelo, Gisela Estrada, Staging, Response to Therapy, and Restaging of Lymphomas with 18F-FDG PET, Archives of Medical Research, 2008, 39, 1, 69

    CrossRef

  75. 75
    H. J. Gallowitsch, I. Igerc, S. Kohlfürst, P. Lind, The Incremental Value of F-18 FDG PET and PET/CT in Malignant Lymphoma, Imaging Decisions MRI, 2008, 12, 4
  76. 76
    Alaa A. Muslimani, Hany L. Farag, Smitha Francis, Timothy P. Spiro, Asif A. Chaudhry, Vincent C. Chan, Harris C. Taylor, Hamed A. Daw, The Utility of 18-F-Fluorodeoxyglucose Positron Emission Tomography in Evaluation of Bone Marrow Involvement by Non-Hodgkin Lymphoma, American Journal of Clinical Oncology, 2008, 31, 5, 409

    CrossRef

  77. 77
    R. Hustinx, G. Jerusalem, B. Deprijk, Tomographie à émission de positons et lymphomes, Médecine Nucléaire, 2008, 32, 8, 449

    CrossRef

  78. 78
    Gérald Bonardel, Stéphane Lecoules, Marina Mantzarides, Thierry Carmoi, Éric Gontier, Jean-Sébastien Blade, Marine Soret, Hervé Foehrenbach, Jean-Pierre Algayres, Tomographie par émission de positons en médecine interne, La Presse Médicale, 2008, 37, 3, 460

    CrossRef

  79. 79
    Ken Herrmann, Bernd Joachim Krause, Fluorine and Health, 2008,

    CrossRef

  80. 80
    Toshio NISHIKAWA, Tomoyoshi MURAMATSU, Akira MATSUMI, A CASE OF PRIMARY MALIGNANT LYMPHOMA OF THE APPENDIX, Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association), 2007, 68, 5, 1183

    CrossRef

  81. 81
    Julio García-Suárez, Helena Bañas, Ignacio Arribas, Dunia De Miguel, Teresa Pascual, Carmen Burgaleta, Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study, British Journal of Haematology, 2007, 136, 2
  82. 82
    Einat Even-Sapir, Genady Lievshitz, Chava Perry, Yair Herishanu, Hedva Lerman, Ur Metser, Fluorine-18 Fluorodeoxyglucose PET/CT Patterns of Extranodal Involvement in Patients with Non-Hodgkin Lymphoma and Hodgkin's Disease, Radiologic Clinics of North America, 2007, 45, 4, 697

    CrossRef

  83. 83
    Berthe M.P. Aleman, John M.M. Raemaekers, Radka Tomiŝiĉ, Margreet H.A. Baaijens, Roberto Bortolus, Marnix L.M. Lybeert, Richard W.M. van der Maazen, Théodore Girinsky, Geertrui Demeestere, Pieternella Lugtenburg, Yolande Lievens, Daphne de Jong, Antonella Pinna, Michel Henry-Amar, Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin’s lymphoma, International Journal of Radiation Oncology*Biology*Physics, 2007, 67, 1, 19

    CrossRef

  84. 84
    Saranya Chumsri, Mohan K. Tummala, Ahsan M. Khna, X. Frank Zhao, Aaron P. Rapoport, Persistent positron emission tomography positivity secondary to benign histiocytic proliferation after treatment of Hodgkin lymphoma, Leukemia & Lymphoma, 2007, 48, 3, 616

    CrossRef

  85. 85
    Cynthia Anderson, Mary Koshy, Charles Staley, Natia Esiashvili, Sharam Ghavidel, Zach Fowler, Tim Fox, Fabio Esteves, Jerome Landry, Karen Godette, PET-CT Fusion in Radiation Management of Patients with Anorectal Tumors, International Journal of Radiation Oncology*Biology*Physics, 2007, 69, 1, 155

    CrossRef

  86. 86
    Luigi Rigacci, Umberto Vitolo, Luca Nassi, Francesco Merli, Andrea Gallamini, Patrizia Pregno, Isabel Alvarez, Flavia Salvi, Rosaria Sancetta, Antonio Castagnoli, Annibale Versari, Alberto Biggi, Michele Gregianin, Ettore Pelosi, Teodoro Chisesi, Alberto Bosi, Alessandro Levis, Positron emission tomography in the staging of patients with Hodgkin’s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi, Annals of Hematology, 2007, 86, 12, 897

    CrossRef

  87. 87
    C. von Falck, B. Maecker, E. Schirg, A.R. Boerner, W.H. Knapp, C. Klein, M. Galanski, Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: A possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring, European Journal of Radiology, 2007, 63, 3, 427

    CrossRef

  88. 88
    Marco Picardi, Amalia De Renzo, Fabrizio Pane, Emanuele Nicolai, Roberto Pacelli, Marco Salvatore, Bruno Rotoli, Randomized comparison of consolidation radiationversusobservation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans, Leukemia & Lymphoma, 2007, 48, 9, 1721

    CrossRef

  89. 89
    Anna M. Kirby, N. George Mikhaeel, The role of FDG PET in the management of lymphoma: what is the evidence base?, Nuclear Medicine Communications, 2007, 28, 5, 335

    CrossRef

  90. 90
    P. Seam, M. E. Juweid, B. D. Cheson, The role of FDG-PET scans in patients with lymphoma, Blood, 2007, 110, 10, 3507

    CrossRef

  91. 91
    Norifumi Tsukamoto, Masaru Kojima, Masatoshi Hasegawa, Noboru Oriuchi, Takafumi Matsushima, Akihiko Yokohama, Takayuki Saitoh, Hiroshi Handa, Keigo Endo, Hirokazu Murakami, The usefulness of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) and a comparison of 18F-FDG-pet with 67gallium scintigraphy in the evaluation of lymphoma, Cancer, 2007, 110, 3
  92. 92
    Gethin Williams, Robin M. Joyce, J Anthony Parker, False-Positive Axillary Lymph Node on FDG-PET/CT Scan Resulting From Immunization, Clinical Nuclear Medicine, 2006, 31, 11, 731

    CrossRef

  93. 93
    Naoto Watanabe, Hiroshi Kato, Jun Murakami, Masashi Shimizu, Kyo Noguchi, Yuichi Kamisaki, Ichiro Matsunari, Hikaru Seto, FDG-PET Imaging in Cutaneous Anaplastic Large Cell Lymphoma, Clinical Nuclear Medicine, 2006, 31, 9, 564

    CrossRef

  94. 94
    Einat Even-Sapir, Genady Lievshitz, Chava Perry, Yair Herishanu, Hedva Lerman, Ur Metser, Fluorine-18 Fluorodeoxyglucose PET/CT Patterns of Extranodal Involvement in Patients with Non-Hodgkin Lymphoma and Hodgkin's Disease, PET Clinics, 2006, 1, 3, 251

    CrossRef

  95. 95
    L Goyal, S Hingmire, Purvish M. Parikh, Newer diagnostic methods in oncology, Medical Journal Armed Forces India, 2006, 62, 2, 162

    CrossRef

  96. 96
    Heok K. Cheow, N. George Mikhaeel, Michael J. O??Doherty, PET and TNM: evolution or revolution?, Nuclear Medicine Communications, 2006, 27, 2, 101

    CrossRef

  97. 97
    M. Galperin-Aizenberg, Y. Volchek, E. Even Sapir, M. Vasserman, Z.V. Maizlin, M. Cohenpour, G. Gayer, Renal extramedullary haematopoiesis mimicking renal lymphoma on computed tomography, Clinical Radiology, 2006, 61, 10, 896

    CrossRef

  98. 98
    Maroun Karam, Leon Novak, Jomol Cyriac, Ameera Ali, Tipu Nazeer, Francis Nugent, Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas, Cancer, 2006, 107, 1